(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

PENTARLANDIR

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

PENTARLANDIR

ST13

US500000090067787

Classe

5

Pedido

90067787

Registro

6466692

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

17

Atualização mais recente

31/08/2021

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5

Data de depósito

22/07/2020

Data de registro

31/08/2021

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

31/08/2021

Última transação

31/08/2021

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use, Foreign priority

Código do desenho

4

Tipo de titular

03

Localização do titular

NEW TAIPEI CITY 22175, TW

Examinador

WILSON, MARYNELLE WEST

Unidade examinadora

M40

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

SyneuRx International (Taiwan) Corp.

Representantes

Michael T. Smith BIRCH STEWART KOLASCH & BIRCH LLP

Classificação técnica

Classes Nice

Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Acids for pharmaceutical purposesaromatic acids for the treatment of viral infection; antibiotics; viral antibiotics; cachets for pharmaceutical purposescachets filled with aromatic acids for the treatment of viral infection; cachou for pharmaceutical purposescachou filled with aromatic acids for the treatment of viral infection; candymedicated; candy for medical purposes; capsules filled with aromatic acids for the treatment of viral infection; chemical preparations for pharmaceutical purposes for the treatment of viral infection; chemical preparations for medical purposes for the treatment of viral infection; chemical preparations for veterinary purposes for the treatment of viral infection; chemical reagents for medical or veterinary purposes; chemico-pharmaceutical preparations for the treatment of viral infection; chewing gum for medical purposes; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic injection and dietetic infusion adapted for medical use; drugs for medical purposes for the treatment of viral infection; flour for pharmaceutical purposes; meal for pharmaceutical purposes; freeze-dried food adapted for medical purposes; lyophilized food adapted for medical purposes; germicides; gum for medical purposes for the treatment of viral infection; homogenized food adapted for medical purposes; medicated animal feed; medicated dentifrices; medicinal infusions for the treatment of viral infection; medicines for human purposes for treatment of viral infection; medicines for veterinary purposes for treatment of viral infection; preparations being cultures of microorganisms for medical or veterinary use; nervines; nutraceutical preparations for treatment of viral infection; nutritional supplements; ointments for treatment of viral infection; cough pastilles for pharmaceutical purposes; cough lozenges for pharmaceutical purposes; pectin for pharmaceutical purposes for treatment of viral infection; pharmaceutical preparations for treatment of viral infection; pharmaceuticals for treatment of viral infection; poultices; pre-filled syringes filled with aromatic acids for the treatment of viral infection; aromatic acid salts for the treatment of viral infection; sedatives; tranquillizers; suppositories for treatment of viral infection; syrups for pharmaceutical purposes for treatment of viral infection; medicated tonics for the treatment of viral infection; inhalation devicesinhalers filled with aromatic acids for the treatment of viral infection; drugs for pulmonary administration for the treatment of viral infection

Publicações

Histórico de despachos e eventos da marca no USPTO.

17 publicações encontradas

R.PR

REGISTERED-PRINCIPAL REGISTER

31/08/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

15/06/2021

PUBO

PUBLISHED FOR OPPOSITION

15/06/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

26/05/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/05/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

27/04/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

27/04/2021

ALIE

ASSIGNED TO LIE

27/04/2021

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

06/04/2021

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

06/04/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

16/03/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/11/2020

GNRT

NON-FINAL ACTION E-MAILED

12/11/2020

CNRT

NON-FINAL ACTION WRITTEN

12/11/2020

DOCK

ASSIGNED TO EXAMINER

05/11/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

19/08/2020

NWAP

NEW APPLICATION ENTERED

25/07/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace PENTARLANDIR ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.